variable | Discovery cohort (n = 71) | Validation cohort (n = 32) | ||||
---|---|---|---|---|---|---|
DGF(n = 23) | IGF(n = 48) | p | DGF(n = 12) | IGF(n = 20) | P | |
Recipient characteristics | ||||||
Age, yr | 39.26 ± 10.767 | 37.35 ± 11.883 | 0.517 | 36.67 ± 13.30 | 37.65 ± 13.95 | 0.846 |
Gender | Â | Â | 0.904 | Â | Â | 0.854 |
 Male | 15(65.2%) | 32(66.7%) |  | 7(58.3%) | 11(55.0%) |  |
 Female | 8(34.8%) | 16(33.3%) |  | 5(41.7%) | 9(45.0%) |  |
BMI, kg/m2 | 22.53 ± 5.01 | 21.49 ± 3.58 | 0.317 | 20.38 ± 4.23 | 20.98 ± 3.20 | 0.654 |
Time on dialysis, m | 36(24–84) | 24(12.5–49.5) | 0.110 | 24(13.75–29.75) | 22(12–60) | 0.876 |
Dialysis,HD | 16(69.6%) | 35(72.9%) | 0.506 | 9(75.0%) | 10(50%) | 0.289 |
Immunosuppression regimen | Â | Â | 0.930 | Â | Â | 0.076 |
ATG,Tac, MMF, steroid | 5(21.7%) | 10(20.8%) | Â | 6(50%) | 4(20.0%) | Â |
Basiliximab,Tac, MMF,steroid | 18(78.3%) | 38(79.2%) | Â | 6(50%) | 16(80.0%) | Â |
Pre-Tx Creatinine, mg/dL | 12.04 ± 3.53 | 12.05 ± 3.79 | 0.988 | 11.19 ± 3.51 | 10.93 ± 3.48 | 0.841 |
history of hypertension | 17(73.9%) | 44(91.7%) | 0.044 | 8(66.7%) | 16(80.0%) | 0.399 |
history of diabetes mellitus | 0(0%) | 3(6.3%) | 0.221 | 0(0%) | 0(0%) | NA |
Donor characteristics | ||||||
Age, yr | 43(35–47) | 46(17–49.75) | 0.631 | 38.50 ± 18.76 | 27.70 ± 15.87 | 0.092 |
Gender | Â | Â | 0.106 | Â | Â | 0.092 |
 Male | 21(91.3%) | 36(75.0%) |  | 11(91.7%) | 13(65.0%) |  |
 Female | 2(8.7%) | 12(25.0%) |  | 1(8.3%) | 7(35.0%) |  |
BMI, kg/m2 | 23.39(18.37–24.46) | 22.49(19.42–24.22) | 0.671 | 24.62(18.53–25.48) | 21.35(18.03–24.46) | 0.226 |
Terminal Creatinine, mg/dL | 1.52(0.87–4.24) | 0.80(0.67–1.08) | 0.001 | 0.37(0.92–1.74) | 0.67(0.56–0.80) | 0.003 |
The donor type | Â | Â | 0.490 | Â | Â | 0.581 |
 DCD | 6(26.1%) | 7(14.6%) |  | 2(16.7%) | 2(10%) |  |
 DBD | 15(65.2%) | 37(77.1%) |  | 10(83.3%) | 18(90%) |  |
 DBCD | 2(8.7%) | 4(8.3%) |  | NA | NA |  |
Donor history of hypertension | 15(65.2%) | 17(35.4%) | 0.018 | 4(33.3%) | 2(10.0%) | 0.102 |
Donor history of diabetes mellitus | 10(43.5%) | 6(12.5%) | 0.003 | 3(25.0%) | 0(0%) | 0.019 |
Transplant characteristics | ||||||
CIT,h | 10.61 ± 2.82 | 8.36 ± 2.27 | 0.001 | 9.5 ± 1.23 | 7.95 ± 1.34 | 0.006 |
HLA mismatches | 5(4–6) | 5(4–5) | 0.663 | 4(4–5.75) | 4.5(4–5) | 0.637 |